Gilead Sciences, Inc. (GILD) operating KPIs
GILDNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 6, 2026Score 11/30105% above fair value
$170.68+5.07 (+3.06%)
Close on Oct 30, 2026Market cap $211.64BP/E –Yield 1.85%
Gilead Sciences arcus Biosciences — Total assets ($M) ($M)
Arcus Biosciences (RCUS) Form 10-Q / 10-K Balance Sheets
Latest, FY2025
1,139
Period ended Dec 31, 2025
Change on a year earlier
-1.0%
1,150 in FY2024
History
7 years
Since FY2019
Sources
7
Documents cited below
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Arcus Biosciences — Total assets ($M) ($M) | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | 1,139 | -1.0% | Arcus Biosciences (RCUS) Form 10-Q (filed 2026-08-05) ↗ |
| FY2024 | Dec 31, 2024 | 1,150 | +5.0% | Arcus Biosciences (RCUS) Form 10-K (filed 2026-02-25) ↗ |
| FY2023 | Dec 31, 2023 | 1,095 | -18.6% | Arcus Biosciences (RCUS) Form 10-K (filed 2025-02-25) ↗ |
| FY2022 | Dec 31, 2022 | 1,345 | -15.5% | Arcus Biosciences (RCUS) Form 10-K (filed 2024-02-21) ↗ |
| FY2021 | Dec 31, 2021 | 1,592 | +106.1% | SEC Filing ↗ |
| FY2020 | Dec 31, 2020 | 772 | +280.3% | SEC Filing ↗ |
| FY2019 | Dec 31, 2019 | 203 | – | SEC Filing ↗ |
Breakdown
What makes up arcus biosciences — total assets ($m)
- Arcus Biosciences — Cash and cash equivalents ($M)222 · FY2025
- Arcus Biosciences — Marketable securities, current ($M)759 · FY2025
- Arcus Biosciences — Unbilled receivables / contract asset from Gilead ($M)11 · FY2025
- Arcus Biosciences — Deferred collaboration revenue, current ($M)35 · FY2025
- Arcus Biosciences — Deferred collaboration revenue, noncurrent ($M)43 · FY2025
- Arcus Biosciences — Total current liabilities ($M)231 · FY2025
- Arcus Biosciences — Total liabilities (legacy XBRL tag, $M)751 · FY2021
Cite this data
StockData. (2026). Gilead Sciences Arcus Biosciences — Total assets ($M) ($M), annual FY2019–FY2025 [Data set]. Compiled from Gilead Sciences SEC filings and investor materials. https://stockdatahq.com/stocks/gild/kpis/rcus_assets_tot
See every metric in the Gilead Sciences KPI table. Data updated Oct 29, 2026.